Edition:
United Kingdom

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

25.98USD
6:54pm BST
Change (% chg)

$-0.16 (-0.61%)
Prev Close
$26.14
Open
$26.30
Day's High
$26.41
Day's Low
$25.80
Volume
272,109
Avg. Vol
781,234
52-wk High
$27.32
52-wk Low
$7.20

Chart for

About

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Its geographic segments include United States and Europe. Its technologies allow it to create humanized... (more)

Overall

Beta: 1.59
Market Cap(Mil.): $1,461.92
Shares Outstanding(Mil.): 125.38
Dividend: --
Yield (%): --

Financials

  IMMU.OQ Industry Sector
P/E (TTM): -- 85.33 32.76
EPS (TTM): -1.44 -- --
ROI: -367.82 2.22 14.61
ROE: -- 3.86 16.34

BRIEF-Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. FDA

* IMMUNOMEDICS SUBMITS BIOLOGICS LICENSE APPLICATION FOR SACITUZUMAB GOVITECAN TO THE U.S. FOOD AND DRUG ADMINISTRATION

21 May 2018

BRIEF-Immunomedics Reports Q3 Loss Per Share $0.21

* IMMUNOMEDICS ANNOUNCES THIRD QUARTER FISCAL 2018 RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

BRIEF-Immunomedics Q2 Loss Per Share $0.02

* IMMUNOMEDICS ANNOUNCES SECOND QUARTER FISCAL 2018 RESULTS AND PROVIDES CORPORATE UPDATE

08 Feb 2018

Competitors

Earnings vs. Estimates